https://www.selleckchem.com/pr....oducts/ethyl-3-amino
clinical practice is expected to improve the overall care of patients with osteoporosis in India. The aim of this study was to prospectively compare the MIFAP protocol, which had been shown to be effective in patients with relapsed and refractory Hodgkin's lymphoma (HL) or aggressive non-Hodgkin's lymphoma (NHL), to an established regimen like Dexa-BEAM. Seventy-three adult patients with HL (N = 25) or aggressive NHL (N = 48) suffering from relapse or refractory disease were randomly allocated to receive t
Aimer
Commentaire
Partagez
